Literature DB >> 15927377

Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis.

David L Shelton1, Jörg Zeller, Wei-Hsien Ho, Jaume Pons, Arnon Rosenthal.   

Abstract

Pain and cachexia are two of the most debilitating aspects of rheumatoid arthritis. Despite that, the mechanisms by which they are mediated are not well understood. We provide evidence that nerve growth factor (NGF), a secreted regulatory protein that controls neuronal survival during development, is a key mediator of pain and weight loss in auto-immune arthritis. Function blocking antibodies to NGF completely reverse established pain in rats with fully developed arthritis despite continuing joint destruction and inflammation. Likewise, these antibodies reverse weight loss while not having any effect on levels of the pro-cachectic agent tumor necrosis factor (TNF). Taken together, these findings argue that pathological joint pain and joint destruction are mechanistically independent processes and that NGF regulates an alternative cachexia pathway that is independent or downstream of TNF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927377     DOI: 10.1016/j.pain.2005.03.039

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  38 in total

1.  The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A.

Authors:  G Castañeda-Corral; J M Jimenez-Andrade; A P Bloom; R N Taylor; W G Mantyh; M J Kaczmarska; J R Ghilardi; P W Mantyh
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

2.  Breast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibers.

Authors:  Aaron P Bloom; Juan M Jimenez-Andrade; Reid N Taylor; Gabriela Castañeda-Corral; Magdalena J Kaczmarska; Katie T Freeman; Kathleen A Coughlin; Joseph R Ghilardi; Michael A Kuskowski; Patrick W Mantyh
Journal:  J Pain       Date:  2011-04-15       Impact factor: 5.820

3.  Nerve growth factor links oral cancer progression, pain, and cachexia.

Authors:  Yi Ye; Dongmin Dang; Jianan Zhang; Chi T Viet; David K Lam; John C Dolan; Jennifer L Gibbs; Brian L Schmidt
Journal:  Mol Cancer Ther       Date:  2011-07-12       Impact factor: 6.261

4.  Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain.

Authors:  Juan M Jimenez-Andrade; Aaron P Bloom; James I Stake; William G Mantyh; Reid N Taylor; Katie T Freeman; Joseph R Ghilardi; Michael A Kuskowski; Patrick W Mantyh
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

5.  Anti-arthritic activity of ferulic acid in complete Freund's adjuvant (CFA)-induced arthritis in rats: JAK2 inhibition.

Authors:  Lijuan Zhu; Zhenshan Zhang; Nannan Xia; Weifeng Zhang; Yanlin Wei; Jiashu Huang; Zhijuan Ren; Feilong Meng; Lei Yang
Journal:  Inflammopharmacology       Date:  2019-09-27       Impact factor: 4.473

6.  Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint.

Authors:  Joseph R Ghilardi; Katie T Freeman; Juan M Jimenez-Andrade; Kathleen A Coughlin; Magdalena J Kaczmarska; Gabriela Castaneda-Corral; Aaron P Bloom; Michael A Kuskowski; Patrick W Mantyh
Journal:  Arthritis Rheum       Date:  2012-07

7.  Antagonism of nerve growth factor-TrkA signaling and the relief of pain.

Authors:  Patrick W Mantyh; Martin Koltzenburg; Lorne M Mendell; Leslie Tive; David L Shelton
Journal:  Anesthesiology       Date:  2011-07       Impact factor: 7.892

Review 8.  Towards a mechanism-based approach to pain management in osteoarthritis.

Authors:  Anne-Marie Malfait; Thomas J Schnitzer
Journal:  Nat Rev Rheumatol       Date:  2013-09-17       Impact factor: 20.543

9.  Systems pharmacology of the nerve growth factor pathway: use of a systems biology model for the identification of key drug targets using sensitivity analysis and the integration of physiology and pharmacology.

Authors:  Neil Benson; Tomomi Matsuura; Sergey Smirnov; Oleg Demin; Hannah M Jones; Pinky Dua; Piet H van der Graaf
Journal:  Interface Focus       Date:  2013-04-06       Impact factor: 3.906

10.  Biologics: target-specific treatment of systemic and cutaneous autoimmune diseases.

Authors:  Siba P Raychaudhuri; Smriti K Raychaudhuri
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.